Decidr AI Divests 13Seeds to Sharpen Focus Amid Rapid Platform Expansion
Decidr AI Industries reported an 82% revenue jump in its AI platform during Q4 FY25, launched AI Mentors with The Growth Faculty, and divested its 13Seeds business to sharpen focus on AI innovation.
- 82% increase in Decidr platform quarterly revenue to A$1.8 million
- New multi-year $296,000 contract with Australian Institute of Management
- Launch of AI Mentors featuring global business authors
- Edible Beauty e-commerce sales up 47% driven by AI-enabled marketing
- Strategic divestment of loss-making 13Seeds business to focus on AI platform
Strong Revenue Growth and Expanding Partnerships
Decidr AI Industries (ASX – DAI) has delivered a robust performance in the June 2025 quarter, with its AI platform, Decidr, achieving an annualised revenue run rate of A$1.8 million. This represents an 82% increase from the previous quarter, underscoring the rapid commercialisation of its agentic AI technology. The company has broadened its reach through new partnerships with notable organisations such as the Australian Institute of Management (AIM), Sugarwork in the US, and SBX Business Brokers, expanding its footprint across enterprise learning, hospitality, and SME brokerage sectors.
AI Mentors Launch and CareerOne Momentum
July 1 marked the official launch of Decidr’s AI Mentors, co-developed with The Growth Faculty, featuring global bestselling business authors. This subscription-based offering is already gaining traction, signaling strong market interest. Additionally, the CareerOne partnership has seen a 161% revenue increase from the prior quarter, driven by AI-enabled job search and talent acquisition tools, highlighting Decidr’s growing influence in HR tech.
Edible Beauty’s E-commerce Surge and AI Enablement
Decidr’s health and wellness arm, Edible Beauty, reported a 47% increase in e-commerce sales compared to the prior corresponding period. This growth is attributed to AI-driven marketing strategies, including the deployment of the Decidr Sales Agent ‘AVA,’ which personalises customer interactions and boosts conversion rates. The launch of new products like the Super Stem Cell Concentrate also contributed significantly to sales momentum.
Strategic Divestment and Financial Health
In a move to streamline operations and concentrate on its core AI platform, Decidr divested the loss-making 13Seeds business. This strategic decision frees up management resources to focus on scaling the DecidrOS platform, which is on track for a Beta release in Q1 FY26. Financially, the company maintains a strong cash position of A$7.75 million, bolstered by option exercises and a recent R&D tax incentive claim, providing a solid runway for growth initiatives.
Looking Ahead
With the DecidrOS platform nearing its Beta launch, the company is poised to accelerate deployment of its agentic AI applications across multiple industries and geographies, including the US and Asia-Pacific. The focus will be on scaling embedded AI apps with partners, onboarding SME clients, and driving recurring revenue streams. The recent executive hires in revenue, partnerships, and marketing roles signal Decidr’s commitment to commercial expansion and operational excellence.
Bottom Line?
Decidr’s strategic focus and strong commercial momentum set the stage for a pivotal FY26 as it scales AI innovation globally.
Questions in the middle?
- How will the DecidrOS Beta launch impact customer acquisition and revenue growth?
- What are the expected financial implications of the 13Seeds divestment on future profitability?
- How effectively can Decidr expand its US and Asia-Pacific presence amid competitive AI markets?
